TSHA
USDTaysha Gene Therapies Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$4.290
Haut
$4.540
Bas
$4.000
Volume
5.02M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.2B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
6.14M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies
Actions Connexes
GIFI
Gulf Island Fabrication Inc.
GHRS
GH Research PLC Ordinary Shares
CHCI
Comstock Holding Companies Inc.
WHG
Westwood Holdings Group Inc
GJT
Synthetic Fixed-Income Securities Inc. Floating Rate Structured Repackaged Asset-Backed Trust Securities Certificates Series 2006-3
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.